Tissue distribution and elimination of estrogenic and anti-inflammatory catechol metabolites from sesaminol triglucoside in rats.
Sesaminol triglucoside (STG) is the main sesame (Sesamum indicum L.) lignan. Like many other plant lignans, STG can be converted to the mammalian lignans by intestinal microbiota. The objectives of the present study were to investigate the distribution of STG metabolite in rats, and the effects of STG and its metabolite on in vitro inflammation and estrogenic activities. STG was metabolized via intestinal microflora to a biologically active catechol moiety which would then be absorbed into the body in rats. After oral administration of STG to Sprague-Dawley rats, the concentrations of major STG metabolites in rectum, cecum, colon, and small intestines are higher than those in liver, lung, kidney, and heart. Its concentration in brain is low but detectable. The present study demonstrates that STG may be metabolized to form the catechol metabolites first by intestinal microflora and then incorporated via intestine absorption into the cardiovascular system and transported to other tissues. Results showed that the catechol metabolites were found to be able to penetrate the tail end of intestines (large intestine) and go through urinary excretion. STG metabolites significantly reduced the production of IL-6 and TNF-alpha in RAW264.7 murine macrophages stimulated with lipopolysaccharide. The estrogenic activities of STG metabolites were also established by ligand-dependent transcriptional activation through estrogen receptors. This study clearly shows that STG has anti-inflammatory and estrogenic activities via metabolism of intestinal microflora.
Jan
Kuo-Ching
KC
Food Industry Research & Development Institute, Hsinchu, Taiwan.
Ku
Kuo-Lung
KL
Chu
Yan-Hwa
YH
Hwang
Lucy Sun
LS
Ho
Chi-Tang
CT
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000032:analysis / Q000378:metabolism* / Q000493:pharmacokinetics; D002396:Catechols / Q000032:analysis / Q000378:metabolism* / Q000493:pharmacokinetics; D002460:Cell Line; D004967:Estrogens / Q000032:analysis / Q000378:metabolism* / Q000493:pharmacokinetics; D005960:Glucosides / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics*; D006801:Humans; D051379:Mice; D010936:Plant Extracts / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D031685:Sesamum / Q000737:chemistry; D014018:Tissue Distribution
D000893:Anti-Inflammatory Agents; D002396:Catechols; D004967:Estrogens; D005960:Glucosides; D010936:Plant Extracts; C518861:sesaminol triglucoside; C034221:catechol